Nonsmall Cell Lung Cancer, Stage IV
Oncology·MeSH: Carcinoma, Non-Small-Cell Lung
Prevalence
6.0 / 100K
Incidence
8.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Nonsmall Cell Lung Cancer, Stage IV?
There are 1 clinical trial targeting Nonsmall Cell Lung Cancer, Stage IV tracked by BioSniper.
What is the prevalence of Nonsmall Cell Lung Cancer, Stage IV?
The estimated prevalence of Nonsmall Cell Lung Cancer, Stage IV is approximately 6.0 per 100,000 population.
Deep-dive into Nonsmall Cell Lung Cancer, Stage IV
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis